ESR1 and cancer: However, the downregulated DEGs were mostly enriched in ESR-mediated signaling, signaling by Notch, signaling by Wnt, PI3K/AKT signaling in cancer, signaling by receptor tyrosine kinases and so on, which were all targets for therapeutic intervention (Figure 8F).